Author (Corporate) | European Commission: DG Enterprise |
---|---|
Series Title | Enterprise Europe |
Series Details | No.21, January-March 2006, p16-17 |
Publication Date | January 2006 |
ISSN | 1680-0516 |
Content Type | Journal | Series | Blog |
Advanced therapies, whether they are gene, cell or tissue based, have enormous potential for the patients who can benefit from them and the companies which succeed in achieving these medical breakthroughs. The Commission’s latest proposal in this area is designed to help both industry and the public, while leaving Member States free to decide whether to allow such research or not. |
|
Source Link | Link to Main Source http://bookshop.europa.eu/en/enterprise-europe-pbNBBH03012/issues/?PublicationKey=NBBH03012&EditionKey=NBBH03012ENC_PDF&CatalogCategoryID=C5gKABstvcoAAAEjZJEY4e5L |
Related Links |
|
Subject Categories | Business and Industry, Culture, Education and Research, Health |
Countries / Regions | Europe |